Delivery Order SPE2DB22D2007-SPE2DB25FH8XB

Award Date 2/7/25
Potential Completion Date 2/10/25
Potential Value $45K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of DIFICID 200 MG TABLET 20S medical products. The contract has a ceiling value of $10,419.42 and a completion date of November 21, 2024. It was awarded by the Defense Logistics Agency (DLA), a defense agency, as a firm fixed-price delivery order. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,754.35 firm fixed-price delivery order is for the supply of DIFICID 200 MG TABLET 20S, a pharmaceutical product. The contract has an ultimate completion date of November 18, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $58,715.10 firm fixed-price delivery order contract is for the supply of DIFICID 200 MG TABLET 20S, a pharmaceutical product. The contract has an ultimate completion date of July 29, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, with a ceiling value of $53,902.80, is for the supply of DIFICID 200 MG TABLET 20S, a pharmaceutical product. The contract is a Firm Fixed Price delivery order, with an ultimate completion date of January 13, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,578.55 firm fixed-price delivery order is for the supply of DIFICID 200 MG TABLET 20S, a pharmaceutical product. The contract has an ultimate completion date of November 20, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $81,994.33, is for the delivery of DIFICID 200 MG TABLET 20S, a pharmaceutical product, with a completion date of March 24, 2023. This award is a part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, valued at $12,201.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of DIFICID 200 MG TABLET 20S, a pharmaceutical product. The contract has an ultimate completion date of February 13, 2025 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the supply of DIFICID 200 MG TABLET 20S, a pharmaceutical product. The Firm Fixed Price delivery order has a ceiling value of $5,364.65 and a period of performance through October 31, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the supply of DIFICID 200 MG TABLET 20S, a pharmaceutical product, with a ceiling value of $28,850.01. The contract has an ultimate completion date of January 26, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This contract award, valued at $32,369.06, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of DIFICID 200 MG TABLET 20S, a pharmaceutical product, with a completion date of February 20, 2024. This contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB25FH8XB
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $44,531.94 with a ceiling value of $44,531.94. The award was issued by the Defense Logistics Agency (DLA) and is for the medical product DIFICID 200 MG TABLET 20S. The contract has an ultimate completion date of February 10, 2025. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating it was open competition.

Generated 5/21/25, 10:20 AM